Dual chamber pacing for patients with hypertrophie obstructive cardiomyopathy: A clinical perspective in 2000

Mayo Clinic Proceedings

Volumn 75, Issue 2, 2000, Pages 173-180

  Erwin III, John P ^a   Nishimura, Rick A ^a   Lloyd, Margaret A ^a   Jamil Tajik, A ^a,b  

^a MAYO CLINIC ROCHESTER   (United States)

^b SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANGINA PECTORIS; ARTICLE; CLINICAL ARTICLE; DYSPNEA; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART PACING; HUMAN; HUMAN TISSUE; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MALE; OXYGEN CONSUMPTION; SYMPTOMATOLOGY;

EID: 0033950642     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-6196(11)64190-6     Document Type: Article

References (34)

1. Wigle ED. Rakowski H. Kimball BP. Williams WG. Hypertrophie cardiomyopathy: clinical spectrum and treatment. Circulation. 1995:92:1680-1692.
2. Louie EK. Edwards LC III. Hypertrophie cardiomyopathy. Prog CardiovascDis. 1994:36:275-308.
3. Maron BJ. Hypertrophie cardiomyopathy. CHIT Prob] Cardin]. 1993:18:639-704.
4. Maron BJ, Bonow RO, Cannon RO III, Léon MB, Epstein SE. Hypertrophie cardiomyopathy: interrelations of clinical manifestations, pathophysiology, and therapy (first of two parts). N Engl J Med. 1987;316:780-789.
5. Marian AJ, Roberts R. Recent advances in the molecular genetics of hypertrophie cardiomyopathy. Circulation. 1995:92:1336-1347.
6. McCully RB, Nishimura RA, Tajik AJ, Schaff HV, Danielson GK. Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy. Circulation. 1996;94:467471.
7. ten Berg JM, Suttorp MJ, Knaepen PJ, Ernst SM, Vermeulen FE, Jaarsma W. Hypertrophie obstructive cardiomyopathy: initial results and long-term follow-up after Morrow septal myectomy. Circulation. 1994;90:1781-1785.
8. Cannon RO III, Dilsizian V, O'Gara PT, et al. Impact of surgical relief of outflow obstruction on thallium perfusion abnormalities in hypertrophie cardiomyopathy. Circulation. 1992:85:1039-1045.
9. Cohn LH, Trehan H, Collins JJ Jr. Long-term follow-up of patients undergoing myotomy/myectomy for obstructive hypertrophie cardiomyopathy. Am J Cardiol. 1992;70:657-660.
10. Fananapazir L, Epstein ND, Curiel RV, Panza JA, Tripodi D, McAreavey D. Long-term results of dual-chamber (ODD) pacing in obstructive hypertrophie cardiomyopathy: evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation. 1994;90:27312742.
11. Fananapazir L, Cannon RO III, Tripodi D, Panza JA. Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy. Circulation. 1992:85:21492161.
12. Jeanrenaud X, Goy JJ, Kappenberger L. Effects of dual-chamber pacing in hypertrophie obstructive cardiomyopathy. Lancet. 1992; 339:1318-1323.
13. Braunwald E. Induced septal infarction: a new therapeutic strategy for hypertrophie obstructive cardiomyopathy [editorial]. Circulation. 1997:95:1981-1982.
14. Oakley CM. Non-surgical ablation of the ventricular septum for the treatment of hypertrophie cardiomyopathy [editorial]. Br Heart J. 1995:74:479-480.
15. Spirito P, McKenna WJ, Schultheiss HP. ODD pacing in obstructive HCM [letter]. Circulation. 1995;92:1670-1673.
16. Nishimura RA, Danielson GK. Dual chamber pacing for hypertrophic obstructive cardiomyopathy: has its time come? [editorial]. Br Heart J. 1993;70:301-303.
17. Kappenberger L, Linde C, Daubert C, et al, PIC Study Group. Pacing in hypertrophie obstructive cardiomyopathy: a randomized crossover study. Eur Heart J. 1997:18:1249-1256.
18. Linde C, Gadler F, Kappenberger L, Ryden L, PIC Study Group, Pacing In Cardiomyopathy. Placebo effect of pacemaker implantation in obstructive hypertrophie cardiomyopathy. Am J Cardiol. 1999:83:903-907.
19. Nishimura RA, Trusty JM, Hayes DL, et al. Dual-chamber pacing for hypertrophie cardiomyopathy: a randomized, double-blind, crossover trial. J Am Coll Cardiol. 1997;29:435-441.
20. Slade AK, Sadoul N, Shapiro L, et al. ODD pacing in hypertrophie cardiomyopathy: a multicentre clinical experience. Heart. 1996; 75:44-49.
21. Maron BJ, Nishimura RA, McKenna WJ, Rakowski H, Josephson ME, Kieval RS. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophie cardiomyopathy: a randomized, doubleblind, crossover study (M-PATHY). Circulation. 1999;99:29272933.
22. Hassenstein P, Storch HH, Schmilz W. Erfahrungen mit der Schrittmacherdauerbehandlung bei Patienten mit obstruktiver Kardiomyopathie. ThoraxchirVaskChir. 1975;23:496-498.
23. Hassenstein P, Wolter HH. Therapeutischer Beherrschung einer bedrohlichen Situation bei der idiopathischen hypertrophischen Subaortenstenose. Verh Dtsch Ges Kreislaufforsch. 1967;33:242246.
24. Duck HJ, Hutschenreiter W, Pankau H, Trenckmann H. Vorhofsynchrone Ventrikelstimulation mit verkürzter a.v. Verzogerungszeit als Therapieprinzip der hypertrophischen obstruktiven Kardiomyopathie. Z Gesamte Inn Med. 1984;39:437-447.
25. Spirito P, Bellone P. Natural history of hypertrophie cardiomyopathy. Br Heart J. 1994;72(suppl):S10-S12.
26. Wigle ED. Impaired left ventricular relaxation in hypertrophie cardiomyopathy: relation to extent of hypertrophy. J Am Coll Cardiol. 1990; 15:814-815.
27. Wigle ED, Sasson Z, Henderson MA, et al. Hypertrophie cardiomyopathy: the importance of the site and the extent of hypertrophy: a review. Prog Cardiovasc Dis. 1985;28:1-83.
28. Pak PH, Maughan WL, Baughman KL, Kieval RS, Kass DA. Mechanism of acute mechanical benefit from VDD pacing in hypertrophied heart: similarity of responses in hypertrophie cardiomyopathy and hypertensive heart disease. Circulation. 1998;98:242-248.
29. Nishimura RA, Hayes DL, Ilstrup DM, Holmes DR Jr, Tajik AJ. Effect of dual-chamber pacing on systolic and diastolic function in patients with hypertrophie cardiomyopathy: acute Doppler echocardiographic and catheterization hemodynamic study. J Am Coll Cardiol. 1996;27:421-430.
30. Symanski JD, Nishimura RA. The use of pacemakers in the treatment of cardiomyopathies. Curr Probl Cardiol. 1996:21:385443.
31. Gadler F, Linde C, Juhlin-Dannfeldt A, Ribeiro A, Ryden L. Influence of right ventricular pacing site on left ventricular outflow tract obstruction in patients with hypertrophie obstructive cardiomyopathy. J Am Coll Cardiol. 1996;27:1219-1224.
32. Ommen SR, Nishimura RA, Squires RW, Schaff HV, Danielson GK, Tajik AJ. Comparison of dual-chamber pacing versus septal myectomy for the treatment of patients with hypertrophie obstructive cardiomyopathy: a comparison of objective hemodynamic and exercise end points. / Am Coll Cardiol. 1999;34:191196.
33. Knight C, Kurbaan AS, Seggewiss H, et al. Nonsurgical septal reduction for hypertrophie obstructive cardiomyopathy: outcome in the first series of patients. Circulation. 1997;95:2075-2081.
34. Sigwart U. Non-surgical myocardial reduction for hypertrophie obstructive cardiomyopathy. Lancet. 1995;346:211-214.